Micelles entrapped microparticles technology: a novel approach to resolve dissolution and bioavailability problems of poorly water soluble drugs

References

• Abdullah, M.A.M., et al., 2007. Formulation and evaluation of dried yeast tablets using different techniques. European journal of pharmaceutics and biopharmaceutics, 67, 253–259.
   PubMed Web of Science ®Google Scholar
• Alhnan, M.A., Murdan, S., and Basit, A.W., 2011. Encapsulation of poorly soluble basic drugs into enteric microparticles: a novel approach to enhance their oral bioavailability. International journal of pharmaceutics, 416 (1), 55–60.
   PubMed Web of Science ®Google Scholar
• Annalisa, C., et al., 2019. Dasatinib/HP-β-CD inclusion complex based aqueous formulation as a promising tool for the treatment of paediatric neuromuscular disorders. International journal of molecular sciences, 20 (3), 591.
   Web of Science ®Google Scholar
• Brookman, L.J., et al., 1997. Pharmacokinetics of valsartan in patients with liver disease. Clinical pharmacology & therapeutics, 62 (3), 272–278.
   PubMed Web of Science ®Google Scholar
• Chew, N.Y., et al., 2005. Effect of amino acids on the dispersion of disodium cromoglycate powders. Journal of pharmaceutical sciences, 94 (10), 2289–2300.
   PubMed Web of Science ®Google Scholar
• Davis, W.W., Pfeiffer, R.R., and Quay, J.F., 1970. Normal and promoted gastrointestinal absorption of water-soluble substances I: induced rapidly reversible hyperabsorptive state in the canine fundic stomach pouch. Journal of pharmaceutical sciences, 59 (7), 960–963.
   PubMed Web of Science ®Google Scholar
• Derendorf, H., et al., 2005. Dipyridamole bioavailability in subjects with reduced gastric acidity. The journal of clinical pharmacology, 45 (7), 845–850.
   PubMed Web of Science ®Google Scholar
• Frank, K.J., et al., 2012. Amorphous solid dispersion enhances permeation of poorly soluble ABT-102: true supersaturation vs. apparent solubility enhancement. International journal of pharmaceutics, 437 (1–2), 288–293.
   PubMed Web of Science ®Google Scholar
• Gerald, J., et al., 2014. Carbon dioxide-mediated generation of hybrid nanoparticles for improved bioavailability of protein kinase inhibitors. Pharmaceutical research, 31 (3), 694–705.
   PubMed Web of Science ®Google Scholar
• Hiroyasu, O., et al., 1986. Gastric acidity dependent bioavailability of cinnarizine from two commercial capsules in healthy volunteers. International journal of pharmaceutics, 29 (2–3), 113–120.
   Web of Science ®Google Scholar
• Honghui, Z. and Hao, Z., 2018. Water-insoluble drugs and their pharmacokinetic behaviors. In: R. Liu, ed. Water-insoluble drug formulation. 3rd ed. Boca Raton, FL: CRC Press, 103–104.
   Google Scholar
• ICH Guideline, 2003. Guidance for industry Q1A (R2). Stability testing of new drug substances and products, Maryland: Center for Drug Evaluation and Research, Food and Drug Administration.
   Google Scholar
• Kammela, K.C., et al., 2012. Formulation and evaluation of enteric coated pellets of omeprazole. International journal of drug development & research, 4 (4), 257–264.
   Google Scholar
• Knoebel, R.W. and Larson, R.A., 2018. Pepsi® or Coke®? Influence of acid on dasatinib absorption. Journal of oncology pharmacy practice, 24 (2), 156–158.
   PubMed Web of Science ®Google Scholar
• Lukyanov, A.N. and Torchilin, V.P., 2004. Micelles from lipid derivatives of water-soluble polymers as delivery systems for poorly soluble drugs. Advanced drug delivery reviews, 56 (9), 1273–1289.
   PubMed Web of Science ®Google Scholar
• Malathi, K., Sudhamani, K., and Srinivas, N., 2014. Formulation and evaluation of dasatinib floating microspheres. International journal of innovative pharmaceutical sciences and research, 2 (9), 2086–2105.
   Google Scholar
• Malik, S.N., Canaham, D.H., and Gouda, M.W., 1975. Effect of surfactants on absorption through membranes III: effects of dioctyl sodium sulfosuccinate and poloxalene on absorption of a poorly absorbable drug, phenolsulfonphthalein, in rats. Journal of pharmaceutical sciences, 64 (6), 987–990.
   PubMed Web of Science ®Google Scholar
• Margareth, M., 2004. Dissolution media simulating fasted and fed states. Dissolution technologies, 11 (2), 16.
   Google Scholar
• Mohamed, Y.A.A.A. and Jaykar, B., 2019. Enhancement of oral bioavailability via solid lipid nanoparticles of anticancer drug dasatinib - an in vitro cytotoxicity and pharmacokinetic study. Asian journal of pharmaceutical and clinical research, 12 (6), 143–145.
   Google Scholar
• Moore, J.W. and Flanner, H.H., 1996. Mathematical comparison of dissolution profiles. Pharmaceutical technology, 20, 64–74.
   Google Scholar
• Parvataneni, D.M., Devraj, R., and Mangamoori, L.N., 2013a. Microparticles-entrapped micelles: a novel delivery system to improve solubility and dissolution rate of poorly water-soluble valsartan. Journal of microencapsulation, 30 (8), 805–816.
   PubMed Web of Science ®Google Scholar
• Parvataneni, D.M., Devraj, R., and Mangamoori, L.N., 2013b. Micellar solubilization in the formulation development of poorly soluble naproxen. Pharmaceutical regulatory affairs, 2 (1), 1–12.
   Google Scholar
• Rao, V.M., Engh, K., and Qiu, Y., 2003. Design of pH-independent controlled release matrix tablets for acidic drugs. International journal of pharmaceutics, 252 (1–2), 81–86.
   PubMed Web of Science ®Google Scholar
• Rong, L., Rose-Marie, D., and Shoufeng, L., 2008. Micellization and drug solubility enhancement. In: R. Liu, ed. Water-insoluble drug formulation. 2nd ed. Boca Raton, FL: CRC Press, 255–306.
   Google Scholar
• Rosen, M.J., 1989. Surfactants and interfacial phenomena. 2nd ed. New York: Wiley.
   Google Scholar
• Sandeep, K.R.A., et al., 2018. Development, optimization, and in vitro characterization of dasatinib-loaded PEG functionalized chitosan capped gold nanoparticles using box–behnken experimental design. Drug development and industrial pharmacy, 44 (3), 493–501.
   PubMed Web of Science ®Google Scholar
• Shruthi, V., et al., 2019. Bioequivalence comparison of pediatric dasatinib formulations and elucidation of absorption mechanisms through integrated PBPK modeling. Journal of pharmaceutical sciences, 108 (1), 741–749.
   PubMed Web of Science ®Google Scholar
• Stahl, K., et al., 2002. The effect of process variables on the degradation and physical properties of spray dried insulin intended for inhalation. International journal of pharmaceutics, 233 (1–2), 227–237.
   PubMed Web of Science ®Google Scholar
• Tapash, K. G. and Bhaskara, R. J., eds., 2004. Micromeritics and rheology. In: Theory and practice of contemporary pharmaceutics. Boca Raton, FL: CRC Press, 146–147.
   Google Scholar
• The United State Pharmacopoeia, National Formulary. 2006. Bulk density and tapped density. Asian, Ed., USP 29-NF 24. The official compendia of standards. United State Pharmacopoeial Convention, Rockville, MD, 2638–2639.
   Google Scholar
• Torchilin, V.P., 2001. Structure and design of polymeric surfactant-based drug delivery systems. Journal of controlled release, 73 (2–3), 137–172.
   PubMed Web of Science ®Google Scholar
• Venkatesh, K. and Selvamuthukumar, S., 2018. Formulation development and characterization of dasatinib nanocrystals and optimization using response surface methodology. International journal of pharma research and health sciences, 6 (1), 2295–2302.
   Google Scholar
• Vogt, M., Kunath, K., and Dressman, J.B., 2008. Dissolution improvement of four poorly water soluble drugs by cogrinding with commonly used excipients. European journal of pharmaceutics and biopharmaceutics, 68 (2), 330–337.
   PubMed Web of Science ®Google Scholar
• William, P.F., et al., 2009. The use of experimental design principles in dissolution method development: development of a discriminating dissolution method for sprycel film-coated tablets. Journal of pharmaceutical innovation, 4 (4), 165–173.
   Web of Science ®Google Scholar
• Yamada, I., et al., 1990. Gastric acidity-dependent bioavailability of commercial sustained release preparations of indomethacin, evaluated by gastric acidity-controlled beagle dogs. Chemical & pharmaceutical bulletin, 38 (11), 3112–3115.
   PubMed Web of Science ®Google Scholar
• Yasmin, B.M. and Prathyusha, R.G., 2018. Formulation and evaluation of dasatinib loaded solid lipid nanoparticles. International journal of pharmacy and pharmaceutical sciences, 10 (12), 14–20.
   Google Scholar